Renée V. Gardner

893 total citations
45 papers, 663 citations indexed

About

Renée V. Gardner is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Renée V. Gardner has authored 45 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 16 papers in Genetics and 8 papers in Oncology. Recurrent topics in Renée V. Gardner's work include Hemoglobinopathies and Related Disorders (13 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Iron Metabolism and Disorders (10 papers). Renée V. Gardner is often cited by papers focused on Hemoglobinopathies and Related Disorders (13 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Iron Metabolism and Disorders (10 papers). Renée V. Gardner collaborates with scholars based in United States, France and United Kingdom. Renée V. Gardner's co-authors include Lolie C. Yu, María Velez, Solo Kuvibidila, Clinton M. Astle, David Harrison, Raj Warrier, Randall Craver, John Graham‐Pole, Samuel Gross and R. Daniel Camerini‐Otero and has published in prestigious journals such as Blood, The Journal of Immunology and The American Journal of Medicine.

In The Last Decade

Renée V. Gardner

44 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renée V. Gardner United States 16 311 220 124 110 92 45 663
Anna Paola Iori Italy 14 399 1.3× 163 0.7× 108 0.9× 95 0.9× 70 0.8× 38 762
Shano Naseem India 12 272 0.9× 179 0.8× 107 0.9× 181 1.6× 45 0.5× 129 798
Ben Saxon Australia 12 356 1.1× 184 0.8× 54 0.4× 62 0.6× 89 1.0× 37 690
C Mahasandana Thailand 16 323 1.0× 130 0.6× 57 0.5× 56 0.5× 89 1.0× 39 579
Shoichi Inaba Japan 16 274 0.9× 101 0.5× 94 0.8× 83 0.8× 52 0.6× 61 681
I. J. Temperley Ireland 13 269 0.9× 236 1.1× 46 0.4× 122 1.1× 64 0.7× 56 766
Efthymia Vlachaki Greece 17 476 1.5× 482 2.2× 60 0.5× 158 1.4× 43 0.5× 112 928
Kanchana Chansung Thailand 13 339 1.1× 171 0.8× 99 0.8× 38 0.3× 29 0.3× 40 544
Mauricette Michallet France 19 484 1.6× 365 1.7× 266 2.1× 86 0.8× 100 1.1× 73 1.2k
Neal S. Young United States 11 586 1.9× 325 1.5× 87 0.7× 122 1.1× 35 0.4× 30 1.1k

Countries citing papers authored by Renée V. Gardner

Since Specialization
Citations

This map shows the geographic impact of Renée V. Gardner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renée V. Gardner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renée V. Gardner more than expected).

Fields of papers citing papers by Renée V. Gardner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renée V. Gardner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renée V. Gardner. The network helps show where Renée V. Gardner may publish in the future.

Co-authorship network of co-authors of Renée V. Gardner

This figure shows the co-authorship network connecting the top 25 collaborators of Renée V. Gardner. A scholar is included among the top collaborators of Renée V. Gardner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renée V. Gardner. Renée V. Gardner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuvibidila, Solo, Renée V. Gardner, María Velez, & Raj Warrier. (2018). Clinical Observations, Plasma Retinol Concentrations, and In Vitro Lymphocyte Functions in Children With Sickle Cell Disease. Ochsner Journal. 18(4). 308–317. 3 indexed citations
2.
Velez, María, et al.. (2018). Impact of Hurricane Katrina on healthcare delivery for New Orleans patients, 2005–2014. Pediatric Blood & Cancer. 65(12). e27406–e27406. 11 indexed citations
3.
Gardner, Renée V.. (2018). Sickle Cell Disease: Advances in Treatment. Ochsner Journal. 18(4). 377–389. 63 indexed citations
5.
Vichinsky, Elliott, Françoise Bernaudin, Gian Luca Forni, et al.. (2011). Long‐term safety and efficacy of deferasirox (Exjade®) for up to 5 years in transfusional iron‐overloaded patients with sickle cell disease. British Journal of Haematology. 154(3). 387–397. 58 indexed citations
6.
Leiva, Lily E., et al.. (2010). Effect of L‐arginine supplementation on immune responsiveness in patients with sickle cell disease. Pediatric Blood & Cancer. 55(2). 318–323. 6 indexed citations
8.
Gardner, Renée V., et al.. (2003). Hemopoietic Function After Use of IL-1 with Chemotherapy or Irradiation. The Journal of Immunology. 171(3). 1202–1206. 7 indexed citations
9.
Kuvibidila, Solo, et al.. (2003). Effects of iron deficiency on the secretion of interleukin‐10 by mitogen‐activated and non‐activated murine spleen cells. Journal of Cellular Biochemistry. 90(2). 278–286. 12 indexed citations
10.
Craver, Randall, et al.. (2002). Use of 2-Chlorodeoxyadenosine to Treat Infantile Myofibromatosis. Journal of Pediatric Hematology/Oncology. 24(1). 59–63. 19 indexed citations
11.
Gardner, Renée V., et al.. (2001). The effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on primitive hematopoietic stem cell (PHSC) function and numbers, after chemotherapy. Experimental Hematology. 29(9). 1053–1059. 16 indexed citations
12.
Gardner, Renée V., et al.. (2001). Analysis of the stem cell sparing properties of cyclophosphamide. European Journal Of Haematology. 67(1). 14–22. 10 indexed citations
13.
Gardner, Renée V., et al.. (2001). Multiple Granulocytic Sarcomas in Acute Myeloblastic Leukemia with Simultaneous Occurrence of t(8:21) and Trisomy 8. Leukemia & lymphoma. 42(5). 1139–1144. 10 indexed citations
14.
Kuvibidila, Solo, et al.. (2000). Association between increased levels of TNF-alpha, decreased levels of prealbumin and retinol-binding protein, and disease outcome.. PubMed Central. 92(10). 485–91. 10 indexed citations
15.
Shetty, Avinash K., Lolie C. Yu, Renée V. Gardner, & Raj Warrier. (1999). Role of chemotherapy in the treatment of infantile fibrosarcoma. Medical and Pediatric Oncology. 33(4). 425–427. 30 indexed citations
16.
Gardner, Renée V.. (1999). Long term hematopoeitic damage after chemotherapy and cytokine. Frontiers in bioscience. 4(5). e47–57. 17 indexed citations
17.
Gardner, Renée V.. (1998). Interferon-gamma (IFN-γ) as a potential radio- and chemo-protectant. American Journal of Hematology. 58(3). 218–223. 5 indexed citations
18.
Craver, Randall, et al.. (1996). Renal collecting duct carcinoma in an 8-year-old child. Pediatric Nephrology. 10(1). 29–32. 10 indexed citations
19.
Gardner, Renée V., Oleg N. Voloshin, & R. Daniel Camerini‐Otero. (1995). The Identification of the Single‐Stranded DNA‐Binding Domain of the Escherichia coli RecA Protein. European Journal of Biochemistry. 233(2). 419–425. 28 indexed citations
20.
Gardner, Renée V. & John Graham‐Pole. (1983). Non-Hodgkin's Lymphoma. Pediatric Annals. 12(4). 322–335. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026